XORTX Therapeutics Inc. (XRTX)

NASDAQ: XRTX · IEX Real-Time Price · USD

1.762

-0.108 (-5.78%)

At close: Jul 2, 2024, 4:00 PM

1.810

+0.048 (2.73%)

After-hours: Jul 2, 2024, 7:55 PM EDT

XORTX Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	3.45	10.43	14.87	0.17	0.78
Cash & Cash Equivalents	3.45	10.43	14.87	0.17	0.78
Cash Growth	-66.96%	-29.83%	8582.07%	-78.18%	-
Receivables	0.06	0.08	0.04	0.01	0.02
Other Current Assets	0.56	0.38	1	1.87	0.01
Total Current Assets	4.07	10.9	15.91	2.06	0.82
Property, Plant & Equipment	0.02	0.09	0	0	0
Goodwill and Intangibles	0.18	0.2	0.2	0.23	0.27
Other Long-Term Assets	1.2	1.19	1.27	0	0
Total Long-Term Assets	1.4	1.48	1.47	0.23	0.27
Total Assets	5.47	12.37	17.38	2.29	1.09
Accounts Payable	0.28	1.45	0.55	1.03	1.15
Current Debt	0.01	0.07	0	0	0.05
Other Current Liabilities	0	0	0	0	0.1
Total Current Liabilities	0.29	1.51	0.55	1.03	1.3
Long-Term Debt	0	0.01	0	0	0
Other Long-Term Liabilities	0.53	3.85	3.63	0	0
Total Long-Term Liabilities	0.53	3.87	3.63	0	0
Total Liabilities	0.83	5.38	4.18	1.03	1.3
Total Debt	0.01	0.08	0	0	0.05
Debt Growth	-85.17%	-	-	-	-
Retained Earnings	-17.85	-15.7	-7.98	-8.04	-6.76
Comprehensive Income	-0.05	-0.05	0.08	0	0
Shareholders' Equity	4.64	7	13.2	1.26	-0.21
Net Cash / Debt	3.44	10.36	14.87	0.17	0.73
Net Cash / Debt Growth	-66.82%	-30.35%	8582.07%	-76.67%	-
Net Cash Per Share	1.73	7.00	13.59	0.23	1.23
Working Capital	3.77	9.38	15.36	1.02	-0.48
Book Value Per Share	2.34	4.73	12.07	1.70	-0.36

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).